ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or...

33
ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ADMINISTRATION et al Doc. 16 Dockets.Justia.com

Transcript of ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or...

Page 1: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca

ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ADMINISTRATION et al Doc. 16

Dockets.Justia.com

http://dockets.justia.com/docket/district-of-columbia/dcdce/1:2012cv00388/153248/
http://docs.justia.com/cases/federal/district-courts/district-of-columbia/dcdce/1:2012cv00388/153248/16/
http://dockets.justia.com/
Page 2: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 3: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 4: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 5: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 6: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 7: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 8: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 9: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 10: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 11: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 12: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 13: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 14: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 15: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 16: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 17: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 18: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 19: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 20: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 21: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 22: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 23: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 24: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 25: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 26: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 27: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 28: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 29: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 30: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 31: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 32: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca
Page 33: ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ... · FDA will then give final approval to one or more abbreviated new drug applications that would ... through which AstraZeneca

New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)

New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)

Sponsor Attestation Checklist for Abbreviated New Drug ... · Sponsor Attestation Checklist for Abbreviated New Drug Submissions (ANDSs) Health Canada Use Only Dossier ID Control

Sponsor Attestation Checklist for Abbreviated New Drug ... · Sponsor Attestation Checklist for Abbreviated New Drug Submissions (ANDSs) Health Canada Use Only Dossier ID Control

TABLE OF CONTENTS - U S Food and Drug Administration … · TABLE OF CONTENTS 1 ... AstraZeneca Pharmaceuticals LP has submitted this supplemental new drug application ... (COPD),

TABLE OF CONTENTS - U S Food and Drug Administration … · TABLE OF CONTENTS 1 ... AstraZeneca Pharmaceuticals LP has submitted this supplemental new drug application ... (COPD),

INDEPENDENT RESEARCH AstraZeneca

INDEPENDENT RESEARCH AstraZeneca

AstraZeneca - MSAC

AstraZeneca - MSAC

Drug and Appliance Abbreviations - NHSBSA · PDF fileHaemo Haemostatic ... Drug and Appliance Abbreviations Replaced 04/2015 (Abbreviated Version) 24 Init* Initation Inj Injectable

Drug and Appliance Abbreviations - NHSBSA · PDF fileHaemo Haemostatic ... Drug and Appliance Abbreviations Replaced 04/2015 (Abbreviated Version) 24 Init* Initation Inj Injectable

CHAPTRE – 3 GROWTH AND CHANGING PROFILE OF THE …shodhganga.inflibnet.ac.in/bitstream/10603/4320/9/09... · 2015. 12. 4. · (FDA) and Abbreviated New Drug Application(ANDA),Drug

CHAPTRE – 3 GROWTH AND CHANGING PROFILE OF THE …shodhganga.inflibnet.ac.in/bitstream/10603/4320/9/09... · 2015. 12. 4. · (FDA) and Abbreviated New Drug Application(ANDA),Drug

Content and Format of Abbreviated New Drug Applications

Content and Format of Abbreviated New Drug Applications

ANDA Submissions - Content and Format of Abbreviated New Drug · PDF fileANDA Submissions - Content and Format of Abbreviated New Drug Applications . Draft Guidance: Impact of GDUFA

ANDA Submissions - Content and Format of Abbreviated New Drug · PDF fileANDA Submissions - Content and Format of Abbreviated New Drug Applications . Draft Guidance: Impact of GDUFA

Transatlantic Antitrust and IPR Developments · an Abbreviated New Drug Application (“ANDA”) to the U.S. Food and Drug Administration (“FDA”) (an application for approving

Transatlantic Antitrust and IPR Developments · an Abbreviated New Drug Application (“ANDA”) to the U.S. Food and Drug Administration (“FDA”) (an application for approving

ANDA Submissions — Amendments to Abbreviated New Drug ...zy.yaozh.com/sda/UCM578371.pdf · Abbreviated New Drug Applications Under GDUFA Guidance for Industry . DRAFT GUIDANCE This

ANDA Submissions — Amendments to Abbreviated New Drug ...zy.yaozh.com/sda/UCM578371.pdf · Abbreviated New Drug Applications Under GDUFA Guidance for Industry . DRAFT GUIDANCE This

CENTER FOR DRUG EVALUATION AND RESEARCH · 505(j) of the Federal Food, Drug, and Cosmetic Act (FD&C), regarding your abbreviated new drug application (ANDA) for Azithromycin for Oral

CENTER FOR DRUG EVALUATION AND RESEARCH · 505(j) of the Federal Food, Drug, and Cosmetic Act (FD&C), regarding your abbreviated new drug application (ANDA) for Azithromycin for Oral

AstraZeneca - CIA

AstraZeneca - CIA

Company’s - AstraZeneca

Company’s - AstraZeneca

AstraZeneca Presentation

AstraZeneca Presentation

Apprenticeships at AstraZeneca

Apprenticeships at AstraZeneca

Global Operations - AstraZeneca

Global Operations - AstraZeneca

Bioinformatics from a drug discovery perspective EMBRACE Workshop, 22-23 March 2007 Niclas Jareborg AstraZeneca R&D Södertälje.

Bioinformatics from a drug discovery perspective EMBRACE Workshop, 22-23 March 2007 Niclas Jareborg AstraZeneca R&D Södertälje.

BUSINESSENGAGEMENT ASTRAZENECA

BUSINESSENGAGEMENT ASTRAZENECA

Artificial Intelligence in Drug DesignArtificial Intelligence in Drug Design Ola Engkvist, Hit Discovery, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden ELRIG

Artificial Intelligence in Drug DesignArtificial Intelligence in Drug Design Ola Engkvist, Hit Discovery, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden ELRIG